Expression of the Proto-oncogene Pokemon in Colorectal Cancer - Inhibitory Effects of an siRNA

  • Zhao, Gan-Ting (Department of Gastroenterology, Heping Hospital of Changzhi Medical College) ;
  • Yang, Li-Juan (Department of Biochemistry and Molecular Biology, Shanxi Medical University) ;
  • Li, Xi-Xia (Department of Biochemistry and Molecular Biology, Shanxi Medical University) ;
  • Cui, Hui-Lin (Department of Histology and Embryology, Shanxi Medical University) ;
  • Guo, Rui (Department of Biochemistry and Molecular Biology, Shanxi Medical University)
  • Published : 2013.09.30


Objective: This study aimed to investigate expression of the proto-oncogene POK erythroid myeloid ontogenic factor (Pokemon) in colorectal cancer (CRC), and assess inhibitory effects of a small interference RNA (siRNA) expression vector in SW480 and SW620 cells. Methods: Semi-quantitative reverse transcription-polymerase chain reaction (PCR) and immunohistochemistry were performed to determine mRNA and protein expression levels of Pokemon in CRC tissues. Indirect immunofluorescence staining was applied to investigate the location of Pokemon in SW480 and SW620 cells. The siRNA expression vectors that were constructed to express a short hairpin RNA against Pokemon were transfected to the SW480 and SW620 cells with a liposome. Expression levels of Pokemon mRNA and protein were examined by real-time quantitative-fluorescent PCR and western blot analysis. The effects of Pokemon silencing on proliferation of SW480 and SW620 cells were evaluated with reference to growth curves with MTT assays. Results: The mRNA expression level of Pokemon in tumor tissues ($0.845{\pm}0.344$) was significantly higher than that in adjacent tumor specimens ($0.321{\pm}0.197$). The positive expression ratio of Pokemon protein in CRC (87.0%) was significantly higher than that in the adjacent tissues (19.6%). Strong fluorescence staining of Pokemon protein was observed in the cytoplasm of the SW480 and SW620 cells. The inhibition ratios of Pokemon mRNA and protein in the SW480 cells were 83.1% and 73.5% at 48 and 72 h, respectively, compared with those of the negative control cells with the siRNA. In the SW620 cells, the inhibition ratios of Pokemon mRNA and protein were 76.3% and 68.7% at 48 and 72 h, respectively. MTT showed that Pokemon gene silencing inhibited the proliferation of SW480 and SW620 cells. Conclusion: Overexpression of Pokemon in CRC may have a function in carcinogenesis and progression. siRNA expression vectors could effectively inhibit mRNA and protein expression of Pokemon in SW480 and SW620 cells, thereby reducing malignant cell proliferation.


Pokemon;colorectal cancer;RNA interference;real-time quantitative-fluorescent PCR;Western blot


  1. Agrawal A, Yang J, Murphy RF, Agrawal DK (2006). Regulation of the p14ARF-Mdm2-p53 pathway: an overview in breast cancer. Exp Mol Pathol, 81, 115-22.
  2. Aggarwal A, Hunter WJ 3rd, Aggarwal H, et al (2010). Expression of leukemia/lymphoma-related factor (LRF/ POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol, 89, 140-8.
  3. Aggarwal H, Aggarwal A, Agrawal DK (2011b). Epidermal growth factor increases LRF/Pokemon expression in human prostate cancer cells. Exp Mol Pathol, 91, 496-501.
  4. Aggarwal H, Aggarwal A, Hunter WJ 3rd, et al (2011a). Expression of leukemia/lymphoma related factor (LRF/ Pokemon) in human benign prostate hyperplasia and prostate cancer. Exp Mol Pathol, 90, 226-30.
  5. Apostolopoulou K, Pateras IS, Evangelou K, et al (2007). Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol, 213, 294-302.
  6. Bolocan A, Ion D, Ciocan DN, Paduraru DN (2012). Prognostic and predictive factors in colorectal cancer. Chirurgia (Bucur), 107, 555-63.
  7. Jeon BN, Yoo JY, Choi WI, et al (2008). Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem, 283, 33199-210.
  8. Choi WI, Jeon BN, Yun CO, et al (2009a). Proto-oncogene FBI-1 represses transcription of p21CIP1 by inhibition of transcription activation by p53 and Sp1. J Biol Chem, 284, 12633-44.
  9. Choi WI, Kim Y, Kim Y, et al (2009b). Eukaryotic translation initiator protein 1A isoform, CCS-3, enhances the transcriptional repression of p21CIP1 by proto-oncogene FBI-1 (Pokemon/ZBTB7A). Cell Physiol Biochem, 23, 359-70.
  10. He S, Liu F, Xie Z, et al (2010). P-Glycoprotein/MDR1 regulates pokemon gene transcription through p53 expression in human breast cancer cells. Int J Mol Sci, 11, 3309-51.
  11. Kim D, Rossi J (2008). RNAi mechanisms and applications. Biotechiques, 44, 613-6.
  12. Li Y, Xu S, Wang X, et al (2013). Tumor-specific RNA interference targeting Pokemon suppresses tumor growth and induces apoptosis in prostate cancer. Urology, 81, 467. e1-7.
  13. Lin CC, Zhou JP, Liu YP, et al (2012). The silencing of Pokemon attenuates the proliferation of hepatocellular carcinoma cells in vitro and in vivo by inhibiting the PI3K/Akt pathway. PLoS One, 7, e51916.
  14. Liu K, Liu F, Zhang N, Liu S, Jiang Y (2012). Pokemon silencing leads to bim-mediated anoikis of human hepatoma cell QGY7703. Int J Mol Sci, 13, 5818-31.
  15. Lunardi A, Guarnerio J, Wang G, et al (2013). Role of LRF/ Pokemon in lineage fate decisions. Blood, 121, 2845-53.
  16. Maeda T, Hobbs RM, Merghoub T, et al (2005b). Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature, 433, 278-85.
  17. Stogios PJ, Chen L, Privé GG (2007). Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator. Protein Sc, 16, 336-42.
  18. Maeda T, Hobbs RM, Pandolfi PP (2005a). The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res, 65, 8575-8.
  19. Nakayashiki H, Nguyen QB (2008). RNA interference: roles in fungal biology. Curr Opin Microbiol, 11, 494-502.
  20. Remo A, Pancione M, Zanella C, et al (2012). Molecular pathology of colorectal carcinoma. A systematic review centred on the new role of the pathologist. Pathologica, 104, 432-41.
  21. Tian Z, Wang H, Jia Z, et al (2010). Tumor-targeted inhibition by a novel strategy - mimoretrovirus expressing siRNA targeting the Pokemon gene. Curr Cancer Drug Targets, 10, 932-41.
  22. Zhang NN, Sun QS, Chen Z, Liu F, Jiang YY (2013). Homeostatic regulatory role of Pokemon in NF-${\kappa}B$ signaling: stimulating both p65 and $I{\kappa}B{\alpha}$ expression in human hepatocellular carcinoma cells. Mol Cell Biochem, 372, 57-64.
  23. Zhang QL, Tian DA, Xu XJ (2011). Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras. Onkologie, 34, 526-31.
  24. Zhao X, Ning Q, Sun X, Tian D (2011). Pokemon reduces Bcl- 2 expression through NF-${\kappa}B$p65: A possible mechanism of hepatocellular carcinoma. Asian Pac J Trop Med, 4, 492-7.
  25. Zhao ZH, Wang SF, Yu L, et al (2008). Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results. Lung Cancer, 62, 113-9.
  26. Zu X, Ma J, Liu H, et al (2011). Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res, 13, R26

Cited by

  1. DEPTOR Expression Negatively Correlates with mTORC1 Activity and Tumor Progression in Colorectal Cancer vol.15, pp.11, 2014,
  2. Pokemon enhances proliferation, cell cycle progression and anti-apoptosis activity of colorectal cancer independently of p14ARF–MDM2–p53 pathway vol.31, pp.12, 2014,
  3. Differences in Zbtb7a expression cause heterogeneous changes in human nasopharyngeal carcinoma CNE3 sublines vol.14, pp.3, 2017,
  4. The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder vol.14, pp.4, 2017,